Sector

The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology

The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...

With a dual mission to serve both patients and the planet, the Switzerland-based CDMO takes on today’s most complex sterile medicines

Four young companies built with intention tackle the future of medicine

Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.

Modern-day medications might finally mean obesity can be viewed as treatable

Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success

Novel techniques for mRNA delivery, capping and more will be key to producing more effective vaccines

Biopharma facilities must address the specific needs and concerns of this dynamic sector

Bright ideas are helping drugs and butterflies take flight

In phase 2 of our OSD series, we cover the resurgence of fixed-dose combinations and the pursuit of effective oral delivery for biologics

In phase III of our OSD series, we cover what's on the horizon for the digital metamorphosis of drug delivery, including 3D printing and robot pills.

The science of ADCs makes for an incredible show

Speed and precision make MS the first choice for the real-time monitoring of fermentation and cell culture off-gas